Industry News
Up to 50 percent of women with advanced-stage ovarian cancer could be cured with 1 treatment model
1/21/2016
Up to half of women with advanced-stage ovarian cancer might be cured, compared to the current 20 per cent survival rate, argues Dr.
Biomarker predicts likely chemo result for stage 2 colon cancer patients
1/21/2016
Researchers find a biomarker that predicts which patients with stage 2 colon cancer - where it has spread to nearby tissue but no further - may benefit from post-surgery chemo.
Up to 50 percent of women with advanced-stage ovarian cancer could be cured with 1 treatment model
1/21/2016
Up to half of women with advanced-stage ovarian cancer might be cured, compared to the current 20 per cent survival rate, argues Dr.
Study results leading to the development of a new type of anticancer agent
1/21/2016
Microtubules, one component of a cell's skeleton, are hollow tubes formed from the polymerization of α- and β-tubulin, which are themselves important structural proteins of the mitotic spindle...
Clarifying the mechanism for making blood cells
1/21/2016
In 1917, Florence Sabin, the first female member of the US National Academy of Sciences, discovered hemangioblasts, the common precursor cells for blood cells and blood vessel endothelia.
Cleveland clinic finds pregnancy-associated melanoma is associated with higher death rates
1/21/2016
Study sought to investigate histopathology, staging, risk factors, and outcomes of cutaneous melanoma in women younger than 50.
Structure of protein complex that plays key role in modulating immune system revealed
1/21/2016
Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have solved the atomic structure of a unique ubiquitin ligase complex.
Gene therapy for rare bleeding disorder factor VII deficiency achieves proof-of-concept
1/21/2016
CHOP researcher leads study of factor VII deficiency in dog model; shows long-term correction, safety and efficacy.
Omega-3s: could genetically modified oil seed crops replace fish?
1/21/2016
A safe, effective and sustainable source of omega-3, the genetically modified plant Camelina sativa, could help to produce enough of the beneficial oil to meet everyone's needs.
NCDB study results define optimal waiting time before surgery following chemoradiotherapy
1/21/2016
Researchers analyzing data from the National Cancer Data Base (NCDB) have found that patients who had a cancer operation at precisely eight weeks--56 days--after the end of combined...